Volume 14, Issue 3, Pages (September 2006)

Slides:



Advertisements
Similar presentations
Copyright © American Speech-Language-Hearing Association
Advertisements

Baculovirus capsid display: a novel tool for transduction imaging
Volume 2, Issue 1, Pages (July 2000)
Volume 138, Issue 2, Pages (February 2010)
Generation of transgenic mice using lentiviral vectors: a novel preclinical assessment of lentiviral vectors for gene therapy  Masahito Ikawa, Nobushige.
Supplementary Figure 2 Secondary transplanted brain tumors from PASC1 express human GH. Immuno-fluorescence staining of brain sections from mice implanted.
Adeno-associated Virus Serotype Vectors Efficiently Transduce Normal Prostate Tissue and Prostate Cancer Cells  Jianzhong Ai, Dan Wang, Qiang Wei, Hong.
Volume 25, Issue 2, Pages (February 2017)
VEGF Gene Delivery to Muscle
Supplementary Figure I
Volume 77, Issue 1, Pages (January 2013)
Generation of transgenic mice using lentiviral vectors: a novel preclinical assessment of lentiviral vectors for gene therapy  Masahito Ikawa, Nobushige.
Baculovirus capsid display: a novel tool for transduction imaging
Volume 4, Issue 6, Pages (December 2001)
Volume 18, Issue 10, Pages (October 2010)
Volume 2, Issue 5, Pages (November 2000)
Volume 15, Issue 2, Pages (February 2007)
Volume 77, Issue 1, Pages (January 2013)
Molecular Therapy - Methods & Clinical Development
Image Restoration for Confocal Microscopy: Improving the Limits of Deconvolution, with Application to the Visualization of the Mammalian Hearing Organ 
Volume 138, Issue 2, Pages (February 2010)
Volume 75, Issue 2, Pages (July 2012)
Volume 4, Issue 6, Pages (December 2001)
Volume 24, Issue 2, Pages (July 2018)
Volume 25, Issue 1, Pages (January 2017)
Volume 2, Issue 1, Pages (July 2000)
A Recombinant Baculovirus Efficiently Generates Recombinant Adeno-Associated Virus Vectors in Cultured Insect Cells and Larvae  Yang Wu, Liangyu Jiang,
Gene delivery to in situ veins: Differential effects of adenovirus and adeno-associated viral vectors  Mohammad H. Eslami, MD, Sidhu P. Gangadharan, MD,
RNA Interference Prevents Autosomal-Dominant Hearing Loss
EphA4-ADAM10 Interplay Patterns the Cochlear Sensory Epithelium through Local Disruption of Adherens Junctions  Jean Defourny, Christiane Peuckert, Klas.
Volume 2, Issue 3, Pages (March 2014)
Volume 18, Issue 4, Pages (April 2010)
Volume 12, Issue 10, Pages (September 2015)
Volume 5, Issue 2, Pages (February 2002)
Volume 25, Issue 3, Pages (March 2017)
Volume 24, Issue 7, Pages (July 2016)
Axonal transport of recombinant baculovirus vectors
Volume 12, Issue 6, Pages (December 2005)
Strong Promoters Are the Key to Highly Efficient, Noninflammatory and Noncytotoxic Adenoviral-Mediated Transgene Delivery into the Brain in Vivo  Christian.
Spatially and Temporally Regulated NRF2 Gene Therapy Using Mcp-1 Promoter in Retinal Ganglion Cell Injury  Kosuke Fujita, Koji M. Nishiguchi, Yukihiro.
Mouse Otocyst Transuterine Gene Transfer Restores Hearing in Mice With Connexin 30 Deletion-associated Hearing Loss  Toru Miwa, Ryosei Minoda, Momoko.
Molecular Therapy - Methods & Clinical Development
Volume 6, Issue 1, Pages (July 2002)
Donna M. Martin, Yehoash Raphael  Molecular Therapy 
Transduction characteristics of adeno-associated virus vectors expressing cap serotypes 7, 8, 9, and Rh10 in the mouse brain  Cassia N. Cearley, John.
Volume 10, Issue 11, Pages (March 2015)
Volume 12, Issue 6, Pages (December 2005)
Improved Retinal Transduction In Vivo and Photoreceptor-specific Transgene Expression Using Adenovirus Vectors With Modified Penton Base  Siobhan M Cashman,
Molecular Therapy - Methods & Clinical Development
Hsp70 Gene Transfer by Adeno-associated Virus Inhibits MPTP-Induced Nigrostriatal Degeneration in the Mouse Model of Parkinson Disease  Zhizhong Dong,
Volume 19, Issue 6, Pages (June 2011)
Volume 13, Issue 3, Pages (March 2006)
Volume 18, Issue 3, Pages (March 2010)
The Lymphocytic Choriomeningitis Virus Envelope Glycoprotein Targets Lentiviral Gene Transfer Vector to Neural Progenitors in the Murine Brain  Colleen.
J.M.I. Malik, Z. Shevtsova, M. Bähr, S. Kügler  Molecular Therapy 
Volume 5, Issue 5, Pages (May 2002)
Volume 6, Issue 3, Pages (September 2002)
Volume 18, Issue 12, Pages (December 2010)
Volume 23, Issue 3, Pages (March 2015)
Fetal Brain-directed AAV Gene Therapy Results in Rapid, Robust, and Persistent Transduction of Mouse Choroid Plexus Epithelia  Marie Reine Haddad, Anthony.
Volume 26, Issue 5, Pages (May 2018)
Volume 119, Issue 6, Pages (December 2000)
Volume 24, Issue 1, Pages (January 2016)
Volume 15, Issue 5, Pages (May 2016)
Volume 21, Issue 4, Pages (April 2013)
Volume 9, Issue 2, Pages (February 2004)
Volume 9, Issue 2, Pages (February 2004)
Molecular Therapy - Methods & Clinical Development
Uta Griesenbach, A. Christopher Boyd  Journal of Cystic Fibrosis 
Foxo3 is expressed in the adult mouse cochlea.
Presentation transcript:

Volume 14, Issue 3, Pages 328-335 (September 2006) In Vivo Delivery of Recombinant Viruses to the Fetal Murine Cochlea: Transduction Characteristics and Long-Term Effects on Auditory Function  Jeffrey C. Bedrosian, Michael Anne Gratton, John V. Brigande, Waixing Tang, Jessica Landau, Jean Bennett  Molecular Therapy  Volume 14, Issue 3, Pages 328-335 (September 2006) DOI: 10.1016/j.ymthe.2006.04.003 Copyright © 2006 The American Society of Gene Therapy Terms and Conditions

FIG. 1 Methods of ex utero and trans-uterine microinjection. The surgical setup of the trans-uterine approach is shown as viewed through the dissecting microscope. (A) The uterus is exposed and the fetuses appear as a “string of beads” following midline laparotomy. (B) The left sagittal profile of the embryo at E12. Visible are the cardinal veins (v) and fourth ventricle (iv). The closed arrow points to the otocyst and the injection spot. (C) The microinjection pipette enters the amniotic sac (closed arrow). The light refracts the pipette tip as it enters the amniotic fluid. (D) After injection, dye is visible in the otocyst. Note the keyhole-shaped filled endolymphatic duct protruding away from the otocyst at the 12 o'clock position. Molecular Therapy 2006 14, 328-335DOI: (10.1016/j.ymthe.2006.04.003) Copyright © 2006 The American Society of Gene Therapy Terms and Conditions

FIG. 2 Sagittal cryosections of the murine cochlear and vestibular systems. eGFP-expressing hair cells and supporting cells are seen with fluorescence microscopy in cochlear and vestibular sagittal cryosections of P0 mice that had been injected at E12. (A) Vestibular section after exposure to AAV2/1 (original magnification 10×). The inset (original magnification 25×) shows transduced hair cells and supporting cells that express eGFP. Anti-myosin VIIa antibody is used as a hair cell marker and the reactive cells appear red. Hair cells that express eGFP as well as myosin VIIa appear green-yellow at the colocalization sites. (B) AAV2/8-injected cryosections are seen at 10× original magnification with a 25× original magnification inset. (C) Cochlear section after exposure to lentivirus and staining with an anti-eGFP antibody followed by FITC for better visualization. The white arrow in the inset indicates a myosin VIIa-stained hair cell. Nonspecific eGFP colocalization with this stain appears yellow-green. (D) Nuclei (stained blue with DAPI) outline the macula in the utricle in a sample from an AAV2/9-injected mouse. eGFP is absent. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.) Molecular Therapy 2006 14, 328-335DOI: (10.1016/j.ymthe.2006.04.003) Copyright © 2006 The American Society of Gene Therapy Terms and Conditions

FIG. 3 Long-term gene expression in IHCs and OHCs. Confocal images of mature cochleae after in utero microsurgical viral injection. (A) A composite image of an apical turn is seen under confocal microscopy at original magnification 25×. Phalloidin, which stains F-actin in hair cells and supporting cells, appears red. A fragment of the cochlear turn is seen at original magnification 63× in the inset, which shows inner and outer hair cells that were transduced and express eGFP. Both images are of a cochlea injected with AAV2/1. White arrows mark OHCs and yellow arrows indicate transduced IHCs. (B) A segment of apical turn from a cochlea injected with lentivirus is seen at original magnification 25×. Three rows of OHCs are observed with a low level of eGFP expression. No IHCs are expressing eGFP. A 63× original magnification inset shows green fluorescent supporting cells indicating viral transduction. (C) A confocal projection image from an uninjected negative control at original magnification 63×. It is stained with phalloidin and exposed at a gain similar to that of the cochlear turn in (B) to demonstrate staining above background in (B). (D and E) AAV2/1- and 2/8-injected modiolar cross sections, respectively, at original magnification 40× are seen under light microscopy. The white arrows indicate infected OHCs and the yellow arrow indicates an infected IHC. (F and G) AAV2/1- and 2/8-injected utricular sections are seen at original magnification 20× under light microscopy. Many green fluorescent hair cells and supporting cells are observed. White arrows point to hair cell stereociliae as an indicator of hair cells. In several images, the cuticular plate can be distinguished by its yellow colabeling. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.) Molecular Therapy 2006 14, 328-335DOI: (10.1016/j.ymthe.2006.04.003) Copyright © 2006 The American Society of Gene Therapy Terms and Conditions

FIG. 4 ABR responses in adult mice following in uterogene transfer. Average ABR thresholds in decibels referenced to sound pressure level (dB SPL) are plotted against frequency for groups of mice injected in utero with each viral vector. Frequencies tested were 8, 16, 24, and 32 kHz. Standard error of the mean ranges are plotted for each data point. A statistically significant threshold shift at each of the frequencies is seen between the lentiviral-injected mouse group and the uninjected controls (P < 0.001). No statistically significant difference between the rAAV-injected groups and controls was observed. Molecular Therapy 2006 14, 328-335DOI: (10.1016/j.ymthe.2006.04.003) Copyright © 2006 The American Society of Gene Therapy Terms and Conditions